Advertisement

Topics

U.S. FDA Approves increased Compassionate Use Patient Cases and Sites for ReCell(R) in ...

19:13 EDT 18 Oct 2016 | BioMedReports - Blog

NORTHRIDGE, CA and PERTH, AUSTRALIA and LONDON, UNITED KINGDOM--(Marketwired - Oct 18, 2016) -

  • Up to 48 patients can now be treated at 15 US

Read more...

Original Article: U.S. FDA Approves increased Compassionate Use Patient Cases and Sites for ReCell(R) in ...

NEXT ARTICLE

More From BioPortfolio on "U.S. FDA Approves increased Compassionate Use Patient Cases and Sites for ReCell(R) in ..."

Quick Search
Advertisement